ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 668 filers reported holding ASTRAZENECA PLC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,911,396 | +16.7% | 88,619 | +1.4% | 0.09% | +1.1% |
| Q1 2024 | $5,922,435 | -0.0% | 87,416 | -0.6% | 0.09% | +6.1% |
| Q4 2023 | $5,924,712 | +20.1% | 87,969 | +20.7% | 0.08% | +7.9% |
| Q3 2023 | $4,934,216 | +38.2% | 72,862 | +46.1% | 0.08% | +43.4% |
| Q2 2023 | $3,570,270 | +17.5% | 49,885 | +13.9% | 0.05% | +12.8% |
| Q1 2023 | $3,039,811 | +24.3% | 43,795 | +21.4% | 0.05% | +20.5% |
| Q4 2022 | $2,445,545 | +19.4% | 36,070 | -3.4% | 0.04% | +8.3% |
| Q3 2022 | $2,048,000 | -14.9% | 37,354 | +2.6% | 0.04% | -10.0% |
| Q2 2022 | $2,407,000 | -17.8% | 36,418 | -17.5% | 0.04% | -4.8% |
| Q1 2022 | $2,927,000 | +25.8% | 44,132 | +10.5% | 0.04% | +35.5% |
| Q4 2021 | $2,326,000 | -8.2% | 39,938 | -5.4% | 0.03% | -13.9% |
| Q3 2021 | $2,535,000 | +82.1% | 42,212 | +81.5% | 0.04% | +80.0% |
| Q2 2021 | $1,392,000 | +96.6% | 23,252 | +80.0% | 0.02% | +42.9% |
| Q3 2020 | $708,000 | -61.4% | 12,917 | -62.8% | 0.01% | -63.2% |
| Q2 2020 | $1,835,000 | -4.2% | 34,694 | -19.1% | 0.04% | -19.1% |
| Q1 2020 | $1,915,000 | -52.8% | 42,882 | -47.3% | 0.05% | -45.3% |
| Q4 2019 | $4,055,000 | -32.2% | 81,344 | -39.4% | 0.09% | -35.3% |
| Q3 2019 | $5,981,000 | -29.2% | 134,153 | -34.5% | 0.13% | -28.9% |
| Q2 2019 | $8,451,000 | +2.6% | 204,703 | +0.5% | 0.19% | +1.1% |
| Q1 2019 | $8,238,000 | +4.0% | 203,762 | -2.3% | 0.18% | -5.6% |
| Q4 2018 | $7,918,000 | -11.3% | 208,476 | -7.5% | 0.20% | -1.0% |
| Q3 2018 | $8,922,000 | -45.9% | 225,471 | -52.0% | 0.20% | -50.9% |
| Q2 2018 | $16,490,000 | +2.1% | 469,700 | +1.7% | 0.40% | -0.5% |
| Q1 2018 | $16,149,000 | +12.3% | 461,805 | +8.8% | 0.40% | +6.0% |
| Q4 2017 | $14,378,000 | 0.0% | 424,389 | 0.0% | 0.38% | +2.4% |
| Q3 2017 | $14,378,000 | +8.8% | 424,389 | +9.5% | 0.37% | +2.2% |
| Q2 2017 | $13,210,000 | +9.7% | 387,503 | +0.2% | 0.36% | +6.4% |
| Q1 2017 | $12,038,000 | – | 386,586 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |